Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/29/2010EP2267006A1 Enterococcus antigens
12/29/2010EP2267005A1 ADP-ribosylating toxin from Listeria monocytogenes
12/29/2010EP2267004A2 Peptide derived from hepatitis C virus
12/29/2010EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266618A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266617A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266616A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266615A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266614A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266613A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266612A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266611A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266610A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266609A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266608A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266607A2 Immunoconjugates for treating cancer
12/29/2010EP2266606A1 Methods and compositions for the prevention and treatment of sepsis
12/29/2010EP2266605A1 Vaccines comprising aluminium adjuvants and histidine
12/29/2010EP2266604A2 Adjuvant systems and vaccines
12/29/2010EP2266603A1 Tumour vaccines
12/29/2010EP2266602A2 Combination approaches for generating immune responses
12/29/2010EP2266601A1 Administration of therapeutic viruses
12/29/2010EP2266550A1 Antagonists of ß-catenin for preventing and/or treating neurodegenerative disorders
12/29/2010EP2266537A2 Compositions and methods for treating cancer
12/29/2010EP2265718A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
12/29/2010EP2265646A1 Reagents and methods for detecting influenza virus proteins
12/29/2010EP2265644A1 A monoclonal antibody and a method thereof
12/29/2010EP2265643A1 Agent for treating disease
12/29/2010EP2265639A1 Compositions comprising antibodies or antibody fragments
12/29/2010EP2265637A1 Targeted identification of immunogenic peptides
12/29/2010EP2265634A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
12/29/2010EP2265633A2 Antigenic protein fragments of streptococcus pneumoniae
12/29/2010EP2265288A1 Methods of treating inflammatory pain
12/29/2010EP2265287A1 Methods of treating chronic pain
12/29/2010EP2265286A1 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
12/29/2010EP2265285A1 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
12/29/2010EP2265284A2 Replication-defective flavivirus vaccines and vaccine vectors
12/29/2010EP2265283A1 Auristatin drug linker conjugates
12/29/2010EP2265281A2 Use of interleukin-1 conjugates in the treatment of diabetes
12/29/2010EP2069782B1 Method for determining the quantity and quality of hybridomas
12/29/2010EP2041286B1 Process for making oligopeptides
12/29/2010EP1987066B1 Methods for treating demyelinating diseases
12/29/2010EP1856531B1 Method for diagnosing multiple sclerosis
12/29/2010EP1856153B1 Ykl-40 monoclonal antibodies
12/29/2010EP1828249B1 Biomarkers for pre-selection of patients for anti-igf1r therapy
12/29/2010EP1694697B1 Surface-located campylobacter jejuni polypeptides
12/29/2010EP1685405B1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/29/2010EP1673398B1 Multispecific deimmunized cd3-binders
12/29/2010EP1599503B1 Endothelial cell specific antibodies and uses thereof
12/29/2010EP1539228B1 Novel composition and methods for the treatment of immune related diseases
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1504095B2 Site specific listeria integration vectors and methods for using the same
12/29/2010EP1446157B1 Antibodies for inhibiting blood coagulation and methods of use thereof
12/29/2010EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
12/29/2010EP1315816B1 Genetically engineered co-expression dna vaccines, construction methods and uses thereof
12/29/2010EP1315519B1 Pharmaceutical compositions and methods useful for treating cancer or liver fibrosis
12/29/2010EP1127069B1 Method of making a monomeric beta-form of a prion protein
12/29/2010CN1935262B Use of red Nocardia cyto skeleton for preparing anti human papillomavirus medicine
12/29/2010CN1929861B CTGF as target for the therapy of diabetic nephropathy
12/29/2010CN1874788B Cd20结合分子 Cd20 binding molecules
12/29/2010CN101932707A Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
12/29/2010CN101932698A Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
12/29/2010CN101932608A Antigen-binding constructs
12/29/2010CN101932607A Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/29/2010CN101932606A Humanized antibodies specific for von willebrand factor
12/29/2010CN101932604A Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
12/29/2010CN101932603A Methods of treating bone-loss disorders using a gm-csf antagonist
12/29/2010CN101932602A Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
12/29/2010CN101932597A Novel wheat allergens
12/29/2010CN101932594A Self-assembling peptide nanoparticles useful as vaccines
12/29/2010CN101932339A Dendritic cell vaccine compositions and uses of same
12/29/2010CN101932337A Properdin modulation of alternative pathway and uses thereof
12/29/2010CN101932336A Pcv2 orf2 virus like particle with foreign amino acid insertion
12/29/2010CN101928728A Method for preparing enterovirus virus-like particle and application thereof
12/29/2010CN101928347A Anti-carcinoembryonic-antigen (CEA) antibody and application thereof
12/29/2010CN101928345A Human source antibody and humanization remolding method thereof
12/29/2010CN101928344A Human monoclonal antibodies against cd20
12/29/2010CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections
12/29/2010CN101926995A Asparagus immunologic adjuvant and influenza vaccines containing same
12/29/2010CN101926994A Turtle shell immunoadjuvant and influenza vaccine containing the same
12/29/2010CN101926993A Adjuvant systems and vaccines
12/29/2010CN101926992A Recombined attenuated live vaccine for preventing and treating I-type or II-type infection of herpes simplex virus and preparation method thereof
12/29/2010CN101926991A Classical swine fever virus vaccine and production method thereof
12/29/2010CN101926990A Swelling cell virus vsocs gene-deleted attenuated live vaccine and preparation method and application thereof
12/29/2010CN101926989A Recombinant attenuated Salmonella typhimurium vector vaccine for expressing JEV (Japanese Encephalitis Virus) immunogenic gene as well as preparation method thereof
12/29/2010CN101926988A Injectable vaccines against multiple meningococcal serogroups
12/29/2010CN101926987A Method for producing piglet paratyphoid live vaccine by using synthetic medium
12/29/2010CN101926986A Vibriosis-resisting attenuated live vaccine and preparation method and application thereof
12/29/2010CN101508978B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
12/29/2010CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
12/29/2010CN101020053B Preparation process of inactivated rotavirus vaccine
12/29/2010CA2768172A1 Novel compositions
12/29/2010CA2766629A1 Immunogenic compositions of staphylococcus aureus antigens
12/29/2010CA2766565A1 Bispecific antibodies that bind to complement proteins
12/29/2010CA2766521A1 Albumin-free botulinum toxin formulations
12/29/2010CA2766377A1 Swine influenza hemagglutinin variants
12/29/2010CA2766211A1 Recombinant rsv antigens
12/29/2010CA2766205A1 Vaccine
12/29/2010CA2766163A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 1823